Work

THU0131 Tofacitinib (CP-690,550), an oral janus kinase inhibitor: Analysis of malignancies across the rheumatoid arthritis clinical programme

Year: 2012

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2012-eular.2096

Authors: X. Mariette, J.R. Curtis, E.B. Lee, R. Riese, I. Kaplan, R. Chew, J. Geier, L. Wang, J.D. Bradley

Institutions: Université Paris-Sud, University of Alabama at Birmingham, Seoul National University, Pfizer (United States)

Language: English

Topic: Rheumatoid Arthritis Research and Therapies

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2317856915

Cites:

Cited by: 10

Related to: 10